Track the EXOZYMES INC. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €66.6m. The latest transaction was disclosed on 25 August 2026 (Levée d'options). Among the most active insiders: Korman Tyler Paz. Every trade is openly available.
13
Insider Decl.
n/a
Thresholds
€9,007
1 ops.
Buy Volume
€13,211
2 ops.
Sell Volume
34Σ signal
Buys €9,007€13,211 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,489 shares@ US$12.5446.3% of flowCommon StockSEC:0001641172-25-015456:0
13 of 13 declarations
Acerca de EXOZYMES INC.
EXOZYMES INC. es una empresa que cotiza en el NASDAQ, centrada en el desarrollo de soluciones enzimáticas. Pone énfasis en la innovación en el sector de la biotecnología.